CLAYTON RUSSELL (Chief Medical Officer) received a stock award from LARIMAR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/19/2024ACC: 0001062993-24-001084
Officer· Chief Medical Officer
Since Jan 2026
+157.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
157.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.50K
Price / share
—
Trade value
—
% of position
New position
1/17/2024
0.00→22.50K
Total
Net shares
+22.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2024 | A · Award | +22.50K | — | — | New position | 0.00 | 22.50K |
| Total | +22.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
135K shares
Shares
+135K
Strike price
4.21
Held after
135K
Exercisable
—
1/17/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock135K shares | 1/17/2024 | A · Award | +135K | 4.21 | — | 135K |